All News #Library
Biotech
Biogen Returns To Its Roots With A West Coast Immunology Outpost
18 Nov 2025 //
FIERCE BIOTECH
Hi-Bio Felzartamab Kidney Rejection: Positive Phase 2 Results In Recipients
25 May 2024 //
PR NEWSWIRE
HI-Bio Announces Felzartamab Granted Breakthrough Therapy Designation
31 Oct 2023 //
PR NEWSWIRE
HI-Bio Initiates Healthy Volunteer Study of HIB210 for Immune-Mediated Diseases
11 Jul 2023 //
PR NEWSWIRE
HI-Bio Announces Positive Phase 2 Data on Felzartamab for Membranous Nephropathy
11 Apr 2023 //
PR NEWSWIRE

Market Place
Sourcing Support